Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis.
about
Investigation of galectin-3 function in the reproductive tract by identification of binding ligands in human seminal plasmaSex differences in renal angiotensin converting enzyme 2 (ACE2) activity are 17β-oestradiol-dependent and sex chromosome-independent.ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.Impaired nutrient signaling and body weight control in a Na+ neutral amino acid cotransporter (Slc6a19)-deficient mouse.ACE/ACE2 ratio and MMP-9 activity as potential biomarkers in tuberculous pleural effusions.Human coronavirus EMC is not the same as severe acute respiratory syndrome coronavirusOcular tropism of respiratory virusesA review of genetic methods and models for analysis of coronavirus-induced severe pneumonitis.The Middle East respiratory syndrome--how worried should we be?Angiotensin-converting enzyme 2 as a therapeutic target for heart failureLack of Association between Angiotensin Converting Enzyme I/D Polymorphism and Unexplained Recurrent Miscarriage in Saudi ArabiaRole of angiotensin II in the development of nephropathy and podocytopathy of diabetes.Angiotensin II and the vascular phenotype in hypertension.Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections.Amino acid transporter B(0)AT1 (slc6a19) and ancillary protein: impact on function.MSCs modified with ACE2 restore endothelial function following LPS challenge by inhibiting the activation of RAS.Pathways of [Ca²⁺]i rise evoked by angiotensin II in MDCK renal tubular cells.ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats.Mesenchymal Stem Cells Overexpressing Angiotensin-Converting Enzyme 2 Rescue Lipopolysaccharide-Induced Lung Injury.Angiotensin-converting enzyme-2 overexpression attenuates inflammation in rat model of chronic obstructive pulmonary disease.The effect of fluvastatin on cardiac fibrosis and angiotensin-converting enzyme-2 expression in glucose-controlled diabetic rat hearts.A novel ACE2 activator reduces monocrotaline-induced pulmonary hypertension by suppressing the JAK/STAT and TGF-β cascades with restored caveolin-1 expression.Will the real angiotensin converting enzyme please stand up?
P2860
Q34268107-BEE6BAA7-EC82-4ADD-867A-DB76D3AAFEE5Q34439831-0F9FA484-602C-4F5D-876D-4412B0371F0FQ34784864-FF6878B8-9728-4A02-AD89-18DDA34E439EQ35128236-14C90E57-B122-4D1D-95C1-D15B87A5A1AEQ36337135-81ADEAF5-3FF1-49F1-8504-693D1692CD66Q36551854-DD7F31C6-D98D-4735-AC90-9BED17218713Q36667382-09E7FF13-F62A-4138-A34D-8E1E62BA12DAQ36739375-6009D13A-804E-4802-A901-9332407097A4Q37105685-EC495CA5-9337-45A6-AFBF-A273DC68BE2EQ37620934-F09A2CC4-6654-40CA-92F2-417D05E58659Q37694920-4CF6D671-122E-4173-B077-7B75DA4BEEACQ37808491-BF26D5BA-03C2-4C25-A8C9-A9DE590AA71BQ37859447-2925EA3A-46B0-45C0-A356-CBEF08E0B5BBQ39197752-B0247A30-655E-4F47-9315-689E407FC72FQ39714458-9DFE6BCB-1849-444D-B74F-871EEB70FD4DQ43833798-F553E73C-80B8-4F6E-9420-C69E48C7A4F6Q44083953-35C2E8E2-AC83-4D40-9ECF-58EEA76D35B0Q45287587-F577C082-8218-4678-BCA9-C0A8F8812FC8Q45869181-0DC8ECE1-3D9A-4099-B07F-2B6F4F62F835Q46947045-9177CCD9-BB68-4C6D-9F73-B1EB25007BE1Q48119889-138AE501-551F-462D-AB83-B361AB8D860FQ52654089-E39CE4C3-A47A-4807-B84A-BC54B443A0EBQ52889216-3EECB6C1-C21B-49C5-BE81-F315A4A5354F
P2860
Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis.
@en
type
label
Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis.
@en
prefLabel
Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis.
@en
P2093
P356
P1433
P1476
Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis.
@en
P2093
Keiji Kuba
Takayo Ohto-Nakanishi
Yumiko Imai
P304
P356
10.1253/CIRCJ.CJ-10-0045
P577
2010-02-04T00:00:00Z